ArticleEMBO molecular medicine2025

SFX-01 is therapeutic against myeloproliferative disorders caused by activating mutations in Shp2.

Hyun-Ju Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.